ALV 317 (Nevirapine Extended Release 400 mg)
Pill with imprint ALV 317 is White, Capsule-shape and has been identified as Nevirapine Extended Release 400 mg. It is supplied by Alvogen Inc.
Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ALV 317
Nevirapine Extended Release
- Imprint
- ALV 317
- Strength
- 400 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alvogen Inc.
- National Drug Code (NDC)
- 47781-0317 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
zinc stearate
Note: Inactive ingredients may vary.
More about nevirapine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: NNRTIs
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.